Su Fu

Su Fu is a professional in the biotechnology and venture capital sectors, currently serving as Vice President of Corporate Development at Architect Therapeutics. Based in the San Francisco Bay Area, Su Fu has a diverse background in the life sciences industry.1

Career Highlights

Current Positions::

• Vice President, Corporate Development at Architect Therapeutics (2023 - Present)
• Senior Associate at ARCH Venture Partners (2021 - Present)

Previous Roles::

• Interim Vice President, Business Development at Orbital Therapeutics (2022 - September 2023)
• Head of Corporate Development at ARCH Newco (2021 - May 2023)
• Market Development & Strategic Alliance at Vir Biotechnology, Inc. (2017 - 2021)

Education and Expertise

Su Fu's educational background includes attending the University of Chicago.1 Their experience spans various aspects of the biotech industry, including:

• Corporate and business development
• Market strategy
• Strategic alliances and partnerships
• Early-stage R&D collaborations

During their time at Vir Biotechnology, Su Fu led market strategy for HBV and pan-respiratory assets, and was involved in COVID-19 partnerships.1

Professional Network

Su Fu maintains a strong professional network, with over 500 connections on LinkedIn.1 Their career trajectory demonstrates a focus on bridging scientific innovation with business strategy in the biotechnology sector.